Dustin Grimes, NP
Acute Care · New Bern, NCNPI 1336766369
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 52.7% of the total.
Across 131 payments — averaging $14.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$977
- Abbott$178
- Medtronic$152
- Abiomed$124
- Amgen$52
- Terumo Medical Corporation$45
- plus $325 from 12 others
What the payments were for
- Food & beverage$1,853100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 90 | $977 |
| Abbott | 10 | $178 |
| Medtronic | 6 | $152 |
| Abiomed | 4 | $124 |
| Amgen | 3 | $52 |
| Terumo Medical Corporation | 3 | $45 |
| Cordis US CORP. | 2 | $44 |
| Johnson & Johnson | 2 | $40 |
| Boston Scientific | 2 | $34 |
| Scpharmaceuticals Inc. | 1 | $30 |
| Vital Connect, Inc | 1 | $27 |
| Eagle Pharmaceuticals, Inc. | 1 | $25 |
| Solventum Corporation | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Cardiovascular Systems Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Novo Nordisk | 1 | $16 |
How this compares
$1,853 in reported general payments places this provider in the 85th percentile of 312 acute care providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 57 | $26,933 |
| EliquisApixaban | 11 | $5,232 |
| ClopidogrelClopidogrel Bisulfate | 104 | $913 |
| Metoprolol Succinate | 24 | $262 |
| Atorvastatin Calcium | 23 | $144 |
| Losartan Potassium | 16 | $74 |
| Carvedilol | 12 | $50 |
Paid to pharmacies, not to this prescriber.
Other acute care in New Bern
- Lauren CowellNew Bern$10K
- Benjamin HocuttGreenville$25K
- Matthew KuhnPinehurst$16K
- Robin TruppApex$14K
- Suzanne HartmannRaleigh$12K
- Leigh CasperSalisbury$12K
- Juliana QuagraineCharlotte$11K
- Sarah GroceGreensboro$10K
- Erica TaylorPinehurst$8K
- Kelly BergenGastonia$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.